Literature DB >> 24829266

Molecular approaches to thyroid cancer diagnosis.

Susan J Hsiao1, Yuri E Nikiforov2.   

Abstract

Thyroid nodules are common, and the accurate diagnosis of cancer or benign disease is important for the effective clinical management of patients. Molecular markers are a helpful diagnostic tool, particularly for cytologically indeterminate thyroid nodules. In the past few years, significant progress has been made in developing molecular markers for clinical use in fine-needle aspiration specimens, including gene mutation panels and gene expression classifiers. With the availability of next generation sequencing technology, gene mutation panels can be expanded to interrogate multiple genes simultaneously and to provide yet more accurate diagnostic information. In addition, recently several new molecular markers of thyroid cancer have been identified that offer diagnostic, prognostic, and therapeutic information that might be of value in guiding individualized management of patients with thyroid nodules.
© 2014 Society for Endocrinology.

Entities:  

Keywords:  molecular marker; prognostic marker; thyroid cancer; thyroid nodule

Mesh:

Substances:

Year:  2014        PMID: 24829266      PMCID: PMC4160369          DOI: 10.1530/ERC-14-0166

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  108 in total

1.  Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.

Authors:  Y E Nikiforov; J M Rowland; K E Bove; H Monforte-Munoz; J A Fagin
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

2.  SeqReporter: automating next-generation sequencing result interpretation and reporting workflow in a clinical laboratory.

Authors:  Somak Roy; Mary Beth Durso; Abigail Wald; Yuri E Nikiforov; Marina N Nikiforova
Journal:  J Mol Diagn       Date:  2013-11-09       Impact factor: 5.568

3.  Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma.

Authors:  T J Musholt; P B Musholt; N Khaladj; D Schulz; G F Scheumann; J Klempnauer
Journal:  Surgery       Date:  2000-12       Impact factor: 3.982

4.  Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.

Authors:  P L Dahia; D J Marsh; Z Zheng; J Zedenius; P Komminoth; T Frisk; G Wallin; R Parsons; M Longy; C Larsson; C Eng
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

5.  PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.

Authors:  Marina N Nikiforova; Paul W Biddinger; Christy M Caudill; Todd G Kroll; Yuri E Nikiforov
Journal:  Am J Surg Pathol       Date:  2002-08       Impact factor: 6.394

6.  Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.

Authors:  Zhaowen Zhu; Manoj Gandhi; Marina N Nikiforova; Andrew H Fischer; Yuri E Nikiforov
Journal:  Am J Clin Pathol       Date:  2003-07       Impact factor: 2.493

7.  Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.

Authors:  R Donghi; A Longoni; S Pilotti; P Michieli; G Della Porta; M A Pierotti
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

8.  Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.

Authors:  Armando Bartolazzi; Fabio Orlandi; Enrico Saggiorato; Marco Volante; Federico Arecco; Ruth Rossetto; Nicola Palestini; Ezio Ghigo; Mauro Papotti; Gianni Bussolati; Marco Paolo Martegani; Federico Pantellini; Angelo Carpi; Maria Rosaria Giovagnoli; Salvatore Monti; Vincenzo Toscano; Salvatore Sciacchitano; Gian Maria Pennelli; Caterina Mian; Maria Rosa Pelizzo; Massimo Rugge; Giancarlo Troncone; Lucio Palombini; Gennaro Chiappetta; Gerardo Botti; Aldo Vecchione; Rino Bellocco
Journal:  Lancet Oncol       Date:  2008-05-19       Impact factor: 41.316

Review 9.  BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications.

Authors:  Mingzhao Xing
Journal:  Endocr Rev       Date:  2007-10-16       Impact factor: 19.871

10.  The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.

Authors:  T Liu; N Wang; J Cao; A Sofiadis; A Dinets; J Zedenius; C Larsson; D Xu
Journal:  Oncogene       Date:  2013-10-21       Impact factor: 9.867

View more
  29 in total

Review 1.  Current methodologies for molecular screening of thyroid nodules.

Authors:  Elisabetta Macerola; Fulvio Basolo
Journal:  Gland Surg       Date:  2018-08

Review 2.  [Individualization of the surgical procedure in response to overdiagnosis and overtreatment in differentiated thyroid carcinomas].

Authors:  J I Staubitz; T J Musholt
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

Review 3.  The immune network in thyroid cancer.

Authors:  Maria Rosaria Galdiero; Gilda Varricchi; Gianni Marone
Journal:  Oncoimmunology       Date:  2016-03-30       Impact factor: 8.110

4.  Genome-wide CpG island methylation and intergenic demethylation propensities vary among different tumor sites.

Authors:  Seung-Tae Lee; Joseph L Wiemels
Journal:  Nucleic Acids Res       Date:  2015-10-12       Impact factor: 16.971

Review 5.  The Management of Thyroid Nodules.

Authors:  Bülent Ulusoy
Journal:  Turk Arch Otorhinolaryngol       Date:  2015-12-01

6.  Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis.

Authors:  Abdul K Siraj; Tariq Masoodi; Rong Bu; Shaham Beg; Saif S Al-Sobhi; Fouad Al-Dayel; Mohammed Al-Dawish; Fowzan S Alkuraya; Khawla S Al-Kuraya
Journal:  Am J Hum Genet       Date:  2016-05-26       Impact factor: 11.025

7.  Characterization of Activating Mutations of the MEK1 Gene in Papillary Thyroid Carcinomas.

Authors:  Nicla Borrelli; Federica Panebianco; Vincenzo Condello; Justine A Barletta; Cihan Kaya; Linwah Yip; Marina N Nikiforova; Yuri E Nikiforov
Journal:  Thyroid       Date:  2019-09       Impact factor: 6.568

Review 8.  Nodular Thyroid Disease and Thyroid Cancer in the Era of Precision Medicine.

Authors:  Carles Zafon; Juan J Díez; Juan C Galofré; David S Cooper
Journal:  Eur Thyroid J       Date:  2017-03-03

9.  Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.

Authors:  Jaroslaw Jendrzejewski; Sandya Liyanarachchi; Rebecca Nagy; Leigha Senter; Paul E Wakely; Andrew Thomas; Fadi Nabhan; Huiling He; Wei Li; Krzysztof Sworczak; Matthew D Ringel; Lawrence S Kirschner; Albert de la Chapelle
Journal:  Thyroid       Date:  2016-07-22       Impact factor: 6.568

10.  A 3-bp Deletion VK600-1E in the BRAF Gene Detected in a Young Woman with Papillary Thyroid Carcinoma.

Authors:  S Dvorakova; V Sykorova; E Vaclavikova; P Sykorova; P Vlcek; D Kodetova; P Lastuvka; J Betka; M Mokrejs; J Vcelak; B Bendlova
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.